Found 25 matching trials
Nicotine Metabolizers and [11C]-(+)-PHNO NA The purpose of this study is to investigate the effects of nicotine metabol...
Show More Location
Centre for Addiction and Mental Health
Learn More & Join Trial
Characterizing Dopamine Receptor Binding in Treatment Resistant Depression N/A It is estimated that 30% of individuals with Major Depressive Disorder (MDD...
Show More Location
Unity Health Toronto
Learn More & Join Trial
Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET PHASE1 The objective of the present study is to use positron emission tomography b...
Show More Location
Center for Addiction and Mental Health
Learn More & Join Trial
Smoking-induced Dopamine Release: a [11C]-(+)-PHNO PET Study in Humans N/A This study will evaluate effects of smoking on the dopaminergic system by u...
Show More Location
Centre for Addiction and Mental Health - 33 Russell St
Learn More & Join Trial
Does the Insula Control Smoking-Induced Dopamine Release? A TMS/[11C]-PHNO Study in Humans. NA Findings from this study may demonstrate how the insula contributes to rewa...
Show More Location
Centre for Addiction and Mental Health
Learn More & Join Trial
Exploring Regulation and Function of Dopamine D3 Receptors in Alcohol Use Disorders: A [11C]-(+)-PHNO Study NA There is a need to better understand the mechanisms underlying alcohol use ...
Show More Location
Centre for Addiction and Mental Health
Learn More & Join Trial
Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD PHASE1 Specific Aim 1: As part of a within-subject, two-days, study design, to det...
Show More Location
Connecticut Mental Health Center
Learn More & Join Trial
Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain PHASE1 This study is being done in healthy volunteers to help researchers understa...
Show More Location
Site Reference ID/Investigator# 12201
Learn More & Join Trial
Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System PHASE1 The research team is investigating Opioid Use Disorder (OUD), a disorder ch...
Show More Location
Yale School of Medicine
Learn More & Join Trial
Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia PHASE1 This is a clinical trial in which 40 participants with schizophrenia will b...
Show More Location
Multiple Locations
Learn More & Join Trial